Brian Sheehy and Iszo Capital’s Top Stock Picks

Iszo Capital is an equity only hedge fund based in New York, NY. It was founded in 2010 by Brian Sheehy, its current manager. So far, the fund has invested mainly in pharmaceutical and healthcare stock, but its portfolio contains industrial and service companies as well. The fund has recently filed its first 13F report, for the quarter ending December 31, 2013. Let’s have a look at Sheehy’s top stock picks and the financials behind them.

Taro Pharmaceutical Industries Ltd. (NYSE:TARO)

Top dog is Taro Pharmaceutical Industries Ltd. (NYSE:TARO). Iszo Capital has reported ownership of 1.1 million shares worth approximately $105 million. The company engages in the research and production of pharmaceuticals mainly in the United states. It has a market cap of $5.0 billion and does not pay a dividend. The stock is traded at a Price to Earnings (P/E) ratio of 17.0 and has a beta of 0.28. For the final quarter of 2013, the company posted net sales of $213.6 million and earnings of $2.59 per share.

Second place goes to AMERCO (NASDAQ:UHAL), a company that provides moving and storage services in Canada and the United States. According to Iszo’s 13F report, the fund holds 37,317 shares valued at $8.7 million.  The company has a market cap of $4.5 billion and pays an annual dividend of $1.0, which represents a yield of 0.4%. Shares are changing hands at a P/E ratio of 13.7 and have a beta of 1.23. For the quarter ending December 31, 2013, the company announced consolidated revenues of $641 million and earnings per share (EPS) of $2.67.

Next up is Navigator Holdings Ltd (NYSE:NVGS). Sheehy acquired 275,800 shares valued at $7.4 million. The company is based in London, United Kingdom and operates gas carriers. Navigator Holdings went public on November 21, 2013 in a $19.00 Initial Public Offering (IPO). 12 million shares were offered and net proceeds of $156.4 million were registered. The company has a market cap of $1.4 billion and does not pay a dividend. The stock is traded at a trailing P/E ratio of 26.6 and has a beta of -0.22, which means that the stock trends in the opposite direction to the market.

Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) is also among the fund’s biggest bets. Iszo reported owning 456,024 shares valued at a little over $4 million. The company engages in marine construction and industrial and commercial demolition. It has a market cap of $484 million and pays a quarterly dividend of $0.25, which equals a 1.03% yield. For the fourth quarter of 2013, the company reported revenues of $216 million and earnings of $0.08 per share. For the current quarter, analysts expect Great Lakes Dredge & Dock to post revenues of $203 million and EPS of $0.09.

Ending the top 5 picks is a pharmaceutical company - Depomed Inc (NASDAQ:DEPO). Sheehy has bought 275,644 shares reportedly worth $2.4 million. Depomed has a market cap of $740 million and the stock has a beta of 1.34. The share price has been trending upwards since May 2013 and has gained 24% so far in 2014 to a current price of $13 per share. According to a preliminary earnings report, the company registered revenues of $22.1 million from both drug sales and licensing.

Disclosure: none.

Recommended reading:

Free Stock Research Report: AerCap Holdings NV (AER)

Free Stock Research Report: URS Corp

Stocks That Both David Einhorn and Insiders Love

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!